SINGLE-ARM STUDY OF BRENTUXIMAB VEDOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY HODGKIN LYMPHOMA WHO ARE INELIGIBLE FOR STEM CELL TRANSPLANTATION OR MULTIAGENT CHEMOTHERAPY

Walewski J., Hellmann A., Siritanaratkul N., Ozsan G. H., Ozcan M., Chuncharunee S., ...More

10th International Symposium on Hodgkin Lymphoma, Cologne, Germany, 22 - 25 October 2016, vol.101, pp.56, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 101
  • City: Cologne
  • Country: Germany
  • Page Numbers: pp.56
  • Dokuz Eylül University Affiliated: Yes